This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Milford, MA-based, Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company’s products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. Waters Division (88.8% of total revenues in 2019) - High Performance and Ultra Performance Liquid Chromatography (HPLC and UPLC). TA Division (11.2% of total revenues in 2019)- Thermal Analysis, Rheometry and Calorimetry.
Here's Why Investing In Waters Corp (WAT) Now Makes Sense
by Zacks Equity Research
Steady demand from pharmaceutical business, solid recurring revenues and modest recovery in industrial markets are proving conducive to Waters Corp's (WAT) impressive performance.
Waters (WAT) Q2 Earnings Beat on Broad-Based Sales Growth
by Zacks Equity Research
Waters Corp's (WAT) third-quarter 2017 earnings beat was driven by broad-based top-line expansion, along with spectacular growth in Europe.
Waters Corp. (WAT) Q3 Earnings Beat Estimates, Sales Strong
by Zacks Equity Research
Waters Corp. (WAT) third-quarter earnings beat estimates comfortably, and revenues grew year over year.
Why Waters (WAT) Might Surprise This Earnings Season
by Zacks Equity Research
Waters (WAT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Why Waters Corp (WAT) Looks Set to Beat on Q3 Earnings
by Zacks Equity Research
Waters Corp (WAT) expects to beat third-quarter 2017 earnings on the back of steady demand from pharmaceutical business, growth in recurring revenues and modest recovery of industrial markets.
Why Is Waters (WAT) Down 2.1% Since the Last Earnings Report?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q2 Earnings Beat on Broad-Based Sales Growth
by Zacks Equity Research
Waters Corp. (WAT) second-quarter 2017 earnings beat was driven by broad-based top-line expansion, along with spectacular growth in Asia.
Waters Corp. (WAT) Q2 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Waters Corp. (WAT) second-quarter earnings beat estimates comfortably, and revenues grew year over year.
Why Earnings Season Could Be Great for Waters Corporation (WAT)
by Zacks Equity Research
Investors might want to consider this stock ahead of earnings Given that Waters Corporation (WAT) has a Zacks Rank #2 (Buy) and an ESP in positive territory.
What to Expect from Shutterfly (SFLY) this Earnings Season?
by Zacks Equity Research
Improved operational efficiency and expansion of its range of products is expected to enhance Shutterfly, Inc.'s (SFLY) second-quarter performance, while higher costs might mar the same.
Why an Earnings Beat is Likely for Waters Corp. (WAT) in Q2
by Zacks Equity Research
Waters Corp.'s (WAT) dominant position in the biopharma end markets and thriving sales in emerging markets will likely help it gain traction in the second quarter.
How Waters Corporation (WAT) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Waters Corporation (WAT) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.
Waters Corp (WAT) Up 3.9% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Waters Corp. (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Ranked Momentum Stocks to Buy for May 16th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 16th:
Waters Corp. (WAT) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Waters Corp. (WAT) first-quarter earnings and revenues beat estimates comfortably.
Waters Corp. Boosts Progenesis QI Software with Proteolabels
by Zacks Equity Research
Premium analytical laboratory instrument and software company, Waters Corporation (WAT), recently expanded its Progenesis QI software with the launch of Proteolabels.
Waters Corp. (WAT) Rolls Out New Products at Pitcon 2017
by Zacks Equity Research
Waters Corporation (WAT) unveiled its latest offerings at the Pittcon Conference and Expo, an annual conference and exposition on laboratory science.
Waters Corp (WAT) Up 7.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Waters Corp (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters Corp. (WAT) Q4 Earnings Beat on Top-Line Strength
by Shradha Bardia
Waters Corp. (WAT) fourth-quarter 2016 earnings and revenues beat estimates.
Waters Corp. (WAT) Q4 Earnings and Revenues Trump Estimates
by Zacks Equity Research
Waters Corp. (WAT) fourth-quarter earnings and revenues beat estimates comfortably.
Waters Corp. (WAT) Q4 Earnings: Will the Stock Disappoint?
by Zacks Equity Research
Waters Corporation (WAT) is set to report fourth-quarter and full-year 2016 earnings results, before the opening bell on Jan 24.
Waters Rolls Out 4 Preparative SFCs to Boost Torus Column
by Zacks Equity Research
In a bid to fortify its Torus SFC column line, leading laboratory analytical instrument and software company, Waters Corporation (WAT), unveiled four preparative supercritical fluid chromatography (SFC) columns.